Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 27;16(1):136.
doi: 10.1186/s13244-025-02015-4.

Washed up: the end of an era for adrenal incidentaloma CT

Affiliations
Review

Washed up: the end of an era for adrenal incidentaloma CT

James H Seow et al. Insights Imaging. .

Abstract

For over 20 years, the two key tenets of adrenal incidentaloma (AI) evaluation have been the upper threshold of 10 Hounsfield units (HU) on noncontrast CT (ncCT) to delineate benignity, and the utilisation of adrenal washout CT (AWCT) to evaluate those above this cutoff. In light of growing recent evidence that challenges these two traditional principles, as well as re-evaluation of the data that led to their acceptance, we conclude that neither of these mainstays of adrenal CT remains relevant in modern AI diagnostic workup. With an appropriate definition of an incidentaloma and endocrine assessment for the majority of adrenal lesions, our analysis establishes that the use of AWCT should be ceased in the assessment of AIs, and that a 20 HU attenuation threshold for lesions < 4 cm should replace the traditional 10 HU threshold to exclude malignancy in this patient population. We therefore propose new recommendations for the management of AIs based primarily on CT attenuation and lesion size on ncCT. CRITICAL RELEVANCE STATEMENT: Increasing the CT attenuation threshold to 20 HU for lesions < 4 cm and eliminating washout CT for true adrenal incidentalomas, together with recommendations for endocrine assessment, will significantly decrease the over-investigation of overwhelmingly benign adrenal lesions, whilst confidently excluding malignancy. KEY POINTS: True incidentalomas exclude current or prior extra-adrenal malignancy and clinically suspected adrenal disease. Adrenal washout CT was never proven in the malignancy-sparse true incidentaloma population. Hormonal correlation in parallel with < 20 HU and < 4 cm thresholds of homogeneous lesions on noncontrast CT excludes malignancy.

Keywords: Adrenal gland neoplasms; Adrenal incidentaloma; Tomography (x-ray computed).

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Management of adrenal incidentalomas on noncontrast CTa. a Table only to be used in conjunction with summarised recommendations. HU, Hounsfield unit

Similar articles

References

    1. Caoili EM, Korobkin M, Francis IR et al (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222:629–633. 10.1148/radiol.2223010766 - PubMed
    1. Mayo-Smith WW, Song JH, Boland GL et al (2017) Management of incidental adrenal masses: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 14:1038–1044. 10.1016/j.jacr.2017.05.001 - PubMed
    1. Fassnacht M, Tsagarakis S, Terzolo M (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 189:G1–G42. 10.1093/ejendo/lvad066 - PubMed
    1. Lee JM, Kim MK, Ko SH et al (2017) Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab 32:200–218. 10.3803/EnM.2017.32.2.200 - PMC - PubMed
    1. Rowe NE, Kumar RM, Schieda N et al (2023) Canadian Urological Association guideline: diagnosis, management, and followup of the incidentally discovered adrenal mass. Can Urol Assoc J 17:12–24. 10.5489/cuaj.8248 - PMC - PubMed

LinkOut - more resources